MLC Medical LLC has partnered with JSC "Farmak", Ukraine’s foremost manufacturer of sterile pharmaceuticals, to expand anesthetic options in the Georgian market.

As part of this agreement, MLC Medical registers Diprofol EDTA (Propofol 10mg/ml) injectable/infusional emulsion. Diprofol is a widely utilized intravenous sedative and anesthetic agent, formulated with EDTA to provide an added antimicrobial safety barrier in surgical and ICU sedation.

This registration enhances the resilience of Georgia's hospital drug supply, offering anesthesiologists a dependable, quality-verified formulation for everyday surgical interventions.

MLC Medical values this ongoing partnership with JSC "Farmak" and remains dedicated to supporting surgical departments with proven anesthesia lines.